You didn't answer my question.
What announcements could the company have made to make you think the trial worked?
The full study is meant to be released in aug/sept, they always said topline results (initial statistical analysis most likely) will be released when available.
IIL not contacting the FDA earlier has nothing to do with MIS416 working or not. It's not impossible to design a trial without the FDA and it has no bearing on the actual drug.
What qualifications do you have that make you think you know better than Innate in regards to how many [patients] and what design they need to trial the drug?
I think regardless of what they are announcing you're always going to be doom and gloom about innate.
*edited
Ann: Trading Halt, page-12
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.005(3.23%) |
Mkt cap ! $41.21M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.0¢ | $56.11K | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 231471 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 405423 | 4 |
View Market Depth
| Last trade - 13.27pm 21/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |